Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy.

por Mainwaring, P. N., Nicolson, M. C., Hickish, T., Penson, R., Joel, S., Slevin, M., Smith, I. E.
Publicado 1997

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

por McKeage, M J, Von Pawel, J, Reck, M, Jameson, M B, Rosenthal, M A, Sullivan, R, Gibbs, D, Mainwaring, P N, Serke, M, Lafitte, J-J, Chouaid, C, Freitag, L, Quoix, E
Publicado 2008

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer

por Small, E J, Saad, F, Chowdhury, S, Oudard, S, Hadaschik, B A, Graff, J N, Olmos, D, Mainwaring, P N, Lee, J Y, Uemura, H, De Porre, P, Smith, A A, Zhang, K, Lopez-Gitlitz, A, Smith, M R
Publicado 2019

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients...

por Chiorean, E. G., Von Hoff, D. D., Reni, M., Arena, F. P., Infante, J. R., Bathini, V. G., Wood, T. E., Mainwaring, P. N., Muldoon, R. T., Clingan, P. R., Kunzmann, V., Ramanathan, R. K., Tabernero, J., Goldstein, D., McGovern, D., Lu, B., Ko, A.
Publicado 2016

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

por Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R
Publicado 2015